Affiches

Affiches électroniques

Cliquez sur le titre du résumé pour voir la présentation de l’affiche électronique.

SCIENCES FONDAMENTALES

BS1.02	Characterization of Gag mutations in HIV-1 subtype A long-term non-progressors
BS1.03	Rates and Patterns of Indels in HIV-1 gp120 Within Hosts
BS1.04	Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking
BS1.05	ART-treated adults with diagnosed atherosclerosis are characterized by a particular expression of Regulatory T-cells
BS2.04	Genetic diversity of HIV proviruses persisting during cART in former viremic controllers
BS2.06	Staphylococcus aureus and Candida albicans Facilitate HIV Reservoir Establishment in CD4+ T-Cells by Promoting RALDH Activity in Dendritic Cells
BS2.07	Persistent HIV Reservoir Suppression by (-)-Hopeaphenol, a Plant-Derived Stilbenoid
BS3.04	Development of an HIV Vaccine Component Based on Carbohydrate Mimicry
BS3.06	Breg Function of Marginal Zone Precursor B-cells is Modulated by BAFF-expressing Dendritic Cells
BS3.07	Epigenetic control of human regulatory T cells (Tregs) during HIV-1 infection
BS4.04	Humanized Mice for Studying HIV Persistence in Long-lived Tissue-resident Macrophages
BSP1.03	Characterization of the Role of Host Cell Decapping Activators DDX6, LSm1-7 and PatL1 in HIV-1 Replication
BSP1.04	Impact of in vitro HIV Infection and TGF-β Stimulation on Human Thymic Regulatory T-cell Development
BSP1.05	The Use of Aspirin to Reduce Inflammation Does Not Adversely Affect Systemic T Regulatory Cells
BSP1.07	Characterization of a G118K plus R263K combination of integrase resistance mutations associated with HIV viral load rebound in a patient failing dolutegravir-based therapy
BSP1.08	A complex interplay between the HIV-1 Env gp120 inner domain and the Phe43 cavity shapes the CD4-binding site
BSP1.09	Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples
BSP1.11	Anti-HIV activity of the human antimicrobial peptide, LL-37, and its truncated peptide, 17BIPHE2
BSP2.02	HIV-1 Infection Disrupts Circadian Patterns of Extracellular Vesicles Abundance and microRNA Contents
BSP2.03	Validity of Dried Blood Spot Testing for Sexually Transmitted and Blood Borne Infections: A Systematic Review
BSP2.04	Daily Variations of Gut Microbial Translocation Markers in ART-treated People Living with HIV
BSP5.01	The Circadian Clock Machinery Regulates HIV Transcription in CD4+ T cells
BSP5.02	The Efficacity of DCIR Inhibitors to Limit HIV-1 Infection
BSP6.01	Validation of integration date estimation methods using a simulation of HIV latent genomes
BSP6.02	HIV Diversity Considerations in the Application of the Intact Proviral Detection Assay (IPDA)
BSP6.03	A case of super-infection with two highly divergent HIV-1 strains: implications for the latent reservoir
BSP6.04	The Characterizing and Understanding the HIV Reservoir for Eradication (CURE) Cohort: a New Resource for Understanding HIV Persistence
BSP6.05	Effect of Thymic Output on the Homeostasis of the HIV Reservoir
BSP7.01	Daily Immunological/Virological Variations in Aviremic ART-treated HIV Participants
BSP8.01	New tools to study the expression of the Antisense Protein gene in the proviral DNA context
BSP8.02	IFITM3 and SERINC5 Exert Distinct Inhibitory Pressures on HIV-1 Env Over the Course of Viral Infection
BSP8.06	Genotyping of HIV-1 isolates infecting children and adolescents with undetectable viral load under antiretroviral therapy
BSP8.08	HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells
BSP8.12	Pseudotyping the Oncolytic Virus MG1 to Enhance Its Ability to Selectively Kill HIV Infected Cells
BSP8.13	A Previously Unidentified Residue Within the Dileucine Motif is Required for HIV-1 Nef Antagonism of the SERINC5 Restriction Factor
BSP8.14	R5 HIV-1 preferentially translocates across genital mucosa while X4 virus is selectively sequestered inside genital epithelial cells and activates Type I IFN signalling
BSP8.16	Modulation of the human nuclear pore complex by HIV-1 and IFN-I
BSP9.01	Caractérisation des monocytes du sang circulant chez des travailleuses du sexe béninoises dans le contexte du VIH
BSP9.02	Associations of Host Genetic Variation with Regulation of Inflammatory Gene Expression and HIV Susceptibility
BSP9.03	Host Genetic Regulation of HIV Set-Point Viral Load in Individuals of African Ancestry
BSP10.04	LAG-3 and PD-1 blocking synergizes to restore invariant Natural Killer T Cell Functionality: Implications for HIV treatment
BSP10.05	Phenotype and Cytokine Expression of Peripheral and Gut-derived γδ T Cell Subsets from HAART-treated HIV+ Individuals and Healthy Controls
BSP10.07	Functional and structural determinants of T-cell receptor-mediated control of HIV
BSP10.08	Interplay between IL-32 and CD96 expression: potential role in cell senescence and persistent inflammation in HIV infection
BSP10.09	Impact of cumulative proportion of life under sustained viral suppression on HIV-specific immune responses and T cell exhaustion in children and adolescents with perinatally-acquired HIV infection
BSP10.10	BAFF/BLyS est impliqué dans la modulation du phénotype Breg des lymphocytes B de la zone marginale
BSP10.11	Detecting LAG3: antibody discrepancies in flow cytometry
BSP10.12	Implications of long-term solvent use on NK activation and function: a risk factor for HIV Acquisition
BSP10.14	Aspirin Use Impacts T Cell Trafficking and Correlates with Lower HIV Target Cells at the Genital Mucosa
BSP11.01	Phylodynamics of HCV Genotypes 3a and 1a in Pakistan
BSP11.02	Drug Efflux Transporters and Drug Metabolic Enzymes in Human Circulating and Testicular T-cell Subsets: Relevance to HIV Pharmacotherapy

SCIENCES CLINIQUES

CS1.03	Risk Factors for Small for Gestational Age and Microcephaly among HIV-Exposed Infants in Montreal, Quebec, Canada
CS1.04	Assessing the Cellular and Mitochondrial Effects of Integrase Inhibitors in a Human Embryonic Stem Cell Model
CS1.06	Breastfeeding by Women Living with HIV in a Resource-Rich Setting: A Multicenter Retrospective Review of Maternal and Infant Management and Outcomes
CS2.01	Successful Aging with HIV: Who and How?
CS2.02	Metformin Decreases Weight and Inflammation in Non-Diabetic People Living with HIV: Link with Microbiota Composition
CS2.03	Pilot Randomized Controlled Trial to Determine the Feasibility and Acceptability of Group Therapy for People Aging with HIV Facing Cognitive Challenges
CS2.04	Frailty is a Unique Entity for People Living with HIV
CS2.05	Prevalence, Predictors and Evolution of Lean Non-alcoholic Fatty Liver Disease in HIV Mono-infected Patients
CS2.06	Incidence of Diabetes Mellitus Among People Living with HIV Compared with HIV Negative Individuals in British Columbia Between 2001-2013
CS2.07	Examining the Utility of the HIV Disability Questionnaire (HDQ) in Clinical Practice: Perspectives of Adults Aging with HIV and Health Care Providers
CS3.01	Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF in Canadians Living with HIV; the BICSTaR Cohort
CS3.06	A Clinically-derived HIV Integrase Sequence Harboring High Levels of Genotypic and Phenotypic Resistance to Integrase Strand Transfer Inhibitors
CS3.08	Dolutegravir-containing HIV therapies appear to increase cellular apoptosis and mitochondrial toxicities in human PBMCs
CS4.04	The HPV Screening and Vaccine Evaluation (HPV-SAVE) Study: Risk Behaviours and Anal Dysplasia in MSM Living with HIV
CS4.05	Identifying Intersectional Gaps in Secondary Mental Health Service Use in the Ontario HIV Treatment Network Cohort Study (OCS)
CS4.06	The relationship between inflammatory biomarkers and CD4 count decline during antiretroviral-untreated HIV: A substudy of the VALIDATE (CTN-240) trial
CSP1.01	Chatbot MARVIN: Development study of an Intelligent Conversational Agent to Promote HIV Patients’ Engagement in Care and Management of ART Adherence Barriers
CSP2.01	Integrase Inhibitor Exposure is Linked to Neurocognitive Deficits in HIV
CSP2.02	Long‐term Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in ART‐Naïve Adults
CSP2.03	Dual Therapy with Boosted Darunavir and Dolutegravir: a Review of the Literature
CSP2.05	Changes in Liver Steatosis, Body Mass Index and Hepatocyte Apoptosis After Switch to Raltegravir
CSP2.07	Neurodevelopment of HIV/ARV-Exposed Uninfected Children Compared with HIV-unexposed Uninfected Children During Early Childhood
CSP3.01	Attitudes Towards Anal Cancer and Screening among Men Who Have Sex with Men Living with HIV: Preliminary Results from the HPV-SAVE Study
CSP3.03	Relevance of CMV and EBV Co-Infection to Chronic Inflammation in HIV Elite Controllers
CSP3.04	Differences in Surveillance for HCC in HIV-Infected Patients with and Without HCV/HBV Coinfection: Insights from the LIVEHIV Cohort
CSP4.01	Dolutegravir-containing ART Regimens are Not Independently Associated with Weight Changes among British Columbians Living with HIV
CSP5.01	Relationship Between Hypertension and Incidence of Diabetes Mellitus Among People Living with HIV in British Columbia Between 2001-2013
CSP5.02	« I have more bad days but the good days are coming » – Pain Experienced Among People Living with HIV Accessing Physiotherapy in a Day Health Program
CSP5.03	Microbial Translocation of Fungal β-D-Glucan is Associated with Cardiovascular Risk in People Living with HIV
CSP5.04	Cardiopulmonary Fitness Changes across a Three-Phased Community-Based Exercise Intervention Study among Adults Living with HIV
CSP5.05	The Feasibility and Impact of a Yoga Intervention on Cognitive and Physical Function Among People Living with HIV: a Pilot Randomized Controlled Trial
CSP6.01	Assessing Antiretroviral Therapy Interruptions at Release from Provincial Correctional Centres to the Community in British Columbia (BC)
CSP6.03	HIV Treatment Outcomes, Barriers, and Facilitators Among Refugees in British Columbia (BC)
CSP7.01	Variation of CD4 count in Pregnant Women Living with HIV
CSP7.02	Potential Interaction Between Dolutegravir and Folate Transporters in First Trimester Human Trophoblast Cell Lines
CSP7.03	Assessing Gaps in Comprehensive HIV Care Across a Typology of Care for Women Living with HIV in Canada
CSP7.04	Impact of In-utero Exposure to Protease Inhibitor-Based Antiretroviral Drug Regimens on Developmental Milestones in Mice
CSP7.05	Maternal and Cord Plasma Bioactive Eicosanoid Profiles Differ Between Pregnant Women Living with HIV on Protease Inhibitor Based-ART and HIV-Negative Pregnant Women
CSP7.06	Patterns of Changing Reproductive Intentions Among Women Living with HIV in Canada
CSP7.07	Age at Menopause in Women Living with HIV (WLWH): a Systematic Review
CSP8.01	An Innovative Training Program to Increase the Competencies of British Columbia’s (BC) Nurse Practitioners (NPs) in HIV Prevention
CSP8.02	Longer Term Safety of F/TAF and F/TDF for HIV PREP: DISCOVER Trial Week 96 Results
CSP8.04	Mental Health and Substance Use Screening Practices among Clients Accessing HIV Testing and Other Sexual Health Services: A Scoping Review
CSP9.01	Depression, dissatisfaction with sleep and cognitive difficulties interfere with work productivity in the Positive Brain Health Now (BHN) study
CSP9.02	A Combination of Anxiety, Depression and Associated Symptoms Explains Function Better Than Mood-specific Measures in the Brain Health Now (BHN) Cohort
CSP10.01	Evaluation of Streamlined HIV Pharmacy Services in a Hospital Based Ambulatory Pharmacy in British Columbia (BC)
CSP10.02	Closing the Gap! Implementing Physiotherapy in an Interdisciplinary HIV Community-Based Care Setting – A Pilot Evaluation
CSP10.03	‘It Shows We Care About Those Issues’: an HIV Patients’ and Care Providers’ Qualitative Needs Assessment for a Smart Patient Portal (Opal)
CSP10.04	Thinking Outside the Box: Evaluating a Virtual Classroom Model to Deliver HIV Primary Care Education to Physicians and Nurse Practitioners Across Saskatchewan
CSP10.05	Disability Experiences and Resilience Strategies of South Asian Women Living with HIV in Southern Ontario
CSP11.01	Association between Untimed Plasma Atazanavir Levels and Renal- or Gallstones
CSP12.01	Efficacy of Integrase Inhibitor and Protease Inhibitor-based Three Drug Regimens in the Presence of the M184V/I Mutation: a Review of the Literature
CSP12.02	Sustained Viral Suppression Among Participants with Pre‐existing M184V/I Who Switched to Bictegravir/Emtricitabine/Tenofovir Alafenamide
CSP13.01	Comparing HIRI-MSM Scores and New STI Diagnosis in PrEP patient follow-up
CSP13.02	The Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial: Characteristics of Men who have Sex with Men Interested in Combined HIV and Syphilis PrEP.

ÉPIDÉMIOLOGIE ET SIENCES DE LA SANTÉ PUBLIQUE

EPH1.04	Incidence of HCV Infection Among gbMSM in British Columbia, Canada: a Population-based Cohort Study
EPH1.06	Is hepatitis C elimination sustainable in populations with ongoing transmission risk? Modelling post-elimination epidemics among people who inject drugs
EPH2.04	Neighbourhood Level Material Deprivation and Complete Immune Response (VL+/CD4+) in the Canadian HIV+ Observational Cohort Collaboration (CANOC)
EPH2.06	Prevalence of and Factors Associated with Syphilis among Gay, Bisexual and Other Men Who Have Sex with Men (GBM) in Montreal, Toronto and Vancouver: Results from the Engage Study
EPH2.08	Incidence rates for oral cavity and oropharyngeal cancers among HIV-positive and HIV-negative individuals in British Columbia: a retrospective cohort study
EPH3.04	HIV Acquisition among Federal Offenders in Canada 2005-2018
EPH3.06	HIV-Related Complications and Overdose are Primary Drivers of Mortality Among Women Living with HIV in the Modern Treatment Era
EPH3.07	HIV Prevention and Treatment Cascades Among Female Sex Workers (FSW) and Men Who Have Sex with Other Men (MSM) in Benin, West Africa
EPH4.01	Developing a Predictive Index for HIV Pre-exposure Prophylaxis (PrEP) Use among Gay, Bisexual and Other men Who Have Sex with Men
EPH4.04	Population-Based HIV Pre-Exposure Prophylaxis (PrEP) in British Columbia (BC): an 18-Month Update on Client Enrollment and Prescriber Participation
EPHP1.01	The Canadian Network on Hepatitis C (CanHepC) Virtual Cascade of Care Cohort (VCCC) Feasibility Study – SK Component
EPHP1.02	An outcome-based statistical framework to select and optimize molecular clustering methods for infectious diseases.
EPHP1.03	The incidence of anal squamous cell carcinoma in a cohort of HIV-positive and HIV-negative individuals in British Columbia, Canada (1990-2015)
EPHP1.04	Future and Existing Trials Have Information to Identify Frailty
EPHP1.05	A Cohort-based Study of Models of Primary Care Among Marginalized People Who Use Drugs in Ottawa, Canada
EPHP1.07	Examining HIV transmission clusters among newly-diagnosed asylum seekers in Montreal, Quebec
EPHP1.08	Cascades of Care for Preventing Vertical HIV Transmission
EPHP1.10	Context is Everything: a Recommendation for Selecting Case Definitions when Using Linked Administrative Health Data in HIV Research
EPHP1.11	Validating the use of viral load results to identify individuals with prior evidence of HIV, Ontario, 2018
EPHP1.12	Trends in HIV Pre-exposure Prophylaxis (PrEP) Use in Canada, 2014–2018
EPHP1.13	Virologic Outcome Measures in HIV Clinical Trials: a Methodological Study
EPHP2.01	Bringing Language specific communities to Toronto to Zero ―There is a need for a NEW campaign (digital intervention) for GB&MSM Latino Men (e.g., PrEP, U=U), GUYS LIKE YOU 2020?
EPHP3.01	A cross-sectional study of prolonged disengagement from clinic among people with HCV receiving care in a low threshold, multidisciplinary clinic
EPHP3.02	Incident Hepatitis C Virus Infection among Gay, Bisexual, and other men who have sex with men in Metro Vancouver: A Prospective Biobehavioural Cohort Study
EPHP3.03	Preliminary Findings from Per-SVR, a Longitudinal Cohort of Hepatitis C Patients Who Achieved Sustained Virologic Response
EPHP3.04	Predicting the Presence of Clinically Significant Depressive Symptoms in the HIV-Hepatitis C Co-infected Population in Canada using Supervised Machine Learning
EPHP3.05	Multiplexed Technologies for Sexually Transmitted Infections: A Systematic Review of Global Evidence on Feasibility, Seropositivity and Impact Outcomes
EPHP3.06	The validation of a novel deprivation index for co-infected individuals with non-attendance of a second visit
EPHP3.07	Perinatal and Obstetrical Outcomes in HIV Mono-Infection and HIV/Hepatitis C Co-Infection
EPHP3.08	HIV Screening and Co-infection Among Persons Diagnosed with Active Tuberculosis in British Columbia, 2009-2018
EPHP4.01	MANDALAS – “Coloring Connections”-An Art therapy group & mental health HIV +/- individuals in Toronto: Social Disconnection a common tale in the HIV Prevention Program, CSSP
EPHP4.02	Trans Latinas Ontario (TLO):  4 Years of Empowering HIV+/at risk Transwomen at the HIV Prevention Program of the Centre for the Spanish-Speaking Peoples (CSSP)
EPHP4.03	Can’t Pass it On: Evaluation of a Pan-Canadian U=U Awareness Campaign
EPHP4.04	“Fib-4 First” Risk-stratification Model in a NAFLD Assessment Pathway for HIV Mono-infected Patients
EPHP4.05	Trends in Knowledge of HIV Status and Efficiency of Testing Programs in Sub-Saharan Africa (2000-2018): a Modeling Study of Survey and HIV Testing Program Data
EPHP4.06	Impact of Screening Criteria for Tenofovir Alafenamide Eligibility in the BC Centre for Excellence in HIV/AIDS (BC-CfE) Drug Treatment Program (DTP)
EPHP4.07	Comparing PrEP Accessibility and Users in Mid- and Large-sized Urban Centres
EPHP4.08	An Epidemiological Model for HIV Self-Testing in Canada
EPHP4.09	Evaluating HIV Rapid/Point of Care Testing Positive Predictive Value among Risk Factor Groups in Ontario, 2011-2018
EPHP4.10	Vertical Transmission in Canada: Canadian Perinatal HIV Surveillance Program
EPHP4.12	Gender Differences in HIV Diagnoses in BC
EPHP5.02	HIV viral load suppression and linked transmission amongst male and female sex workers in the Nairobi Sex Worker Outreach Programme (SWOP)
EPHP5.04	Standardized Mortality Ratio among Street-Connected Youth with a High Burden of HIV in an Urban Setting in Sub-Saharan Africa
EPHP5.05	Awareness and Uptake of HIV Pre-exposure Prophylaxis Among Gay and Other Men Who Have Sex with Men in Ontario
EPHP5.08	Sociodemographic Characteristics of HIV Positive Gay and Other Men who Have Sex with Men in Ontario
EPHP5.10	Do men who have sex with men in sub-Saharan Africa have lower knowledge of HIV status than the national average for all men? A meta-analysis of estimates in 22 countries
EPHP5.11	Accès Aux Soins et Services de Santé des PVVIH Issues de L’immigration, Sans Assurance Maladie. Une Revue Narrative Systematique
EPHP5.12	HIV 90-90-90 targets and the care continuum: findings from the Tracks survey among people who inject drugs in Canada, Phase 4 (2017-2019)
EPHP6.02	CODE BLUE! CODE BLUE! Spanish-Speaking gbMSMindividuals in Canada and HIV, a language ethno-specific population need, in a Canadian HIV to Zero strategy ―ESTAMOS AQUI!
EPHP6.04	Reasons for Declining PrEP Referrals among Gay, Bisexual and Other Men Who Have Sex With Men (gbMSM) at PRIMP study Implementation Sites in Toronto
EPHP6.05	Operational Diversity Among Clinics in the PRIMP Study on Scaling Up PrEP Implementation for gbMSM in British Columbia and Ontario
EPHP6.06	Changing demographic and HIV risk behaviors of clients of female sex workers in Karnataka, India
EPHP6.07	Addressing and Responding to Needs of People Living with HIV in the Montreal Region Without Healthcare Coverage
EPHP6.09	Using the Theoretical Domains Framework to identify barriers and facilitators for PrEP implementation in Colombia – The PrEP-Col Study
EPHP6.10	Predictors of Intention to Provide PrEP in Health-care Workers in HIV Clinics in Colombia: Application of the Theoretical Domain Framework – The PrEP Col Study
EPHP6.11	Informing the path towards HIV elimination in Montreal among men who have sex with men through HIV combination prevention: a mathematical modelling approach
EPHP6.12	Characteristics of the HIV cascade of care and unsuppressed viral load among HIV positive gbMSM across three Canadian cities
EPHP6.15	HIV Pre-exposure Prophylaxis (PrEP) Adoption in Primary Care: An Online Survey of Ontario Physicians
EPHP8.01	Partner Notification for Bacterial STIs among Gay, Bisexual and Other Men Who Have Sex with Men (GBM) in Vancouver, Toronto and Montreal: Results from the Engage Study
EPHP8.02	Towards Disability-informed HIV Screening in the United States: a Cross-sectional Study Examining the Relationship Between Disability and HIV Testing Using NHANES Data
EPHP8.04	Who is Prescribing PrEP? A Characterization of Ontario Clinicians Prescribing HIV Pre-Exposure Prophylaxis
EPHP8.05	Attitudinal Factors Associated with Condom use among Heterosexual African Caribbean Black (ACB) Men in Ontario
EPHP8.06	HIV Services Access Among Men who have Sex with Men (MSM) in the Region of Waterloo: Insights from the OutLook Study
EPHP8.07	Is Dating App/Website Use Associated with Sexual Behaviours at Risk for STBBI Transmission? Results from Engage-Montréal
EPHP8.08	A national HIV Testing Strategy: Determining Best Practices and Barriers
EPHP8.13	Assessing Adherence, Follow-up, and Effectiveness for Patients on HIV Pre-exposure Prophylaxis Outside a Major Urban Centre
EPHP9.01	Chemsex and symptoms of anxiety and depression among gay, bisexual, and other men who have sex with men (GBM) in Montréal: Results from the ENGAGE study.
EPHP9.03	Mechanisms in the Relationship Between Crystal Methamphetamine Use and STI Diagnosis and HIV/STI Risks in Gay, Bisexual, and Other Men Who Have Sex with Men (gbMSM)
EPHP9.04	Tobacco Smoking and Complete Immune Response (VL+/CD4+) in the Canadian HIV+ Observational Cohort Collaboration (CANOC)
EPHP10.01	Task-shifting in HIV Testing Services
EPHP10.02	Programmatic approaches for successful linkage to HIV care
EPHP10.03	Practical cognitive rehabilitation strategies to tackle cognitive concerns in people with HIV
EPHP10.05	Caesarean Sections Among Women Living with HIV: a Population-Based Retrospective Cohort Study
EPHP11.01	Implementation of Tracks: Survey of determinants of HIV and hepatitis C among Indigenous Peoples in Canada in First Nations Communities in 2019
EPHP11.03	(Re)Defining Meaningful Engagement with Community: Lessons from a study on racial disparities in health outcomes of MSM living with HIV in a national HIV cohort study
EPHP11.04	Engaging Older Adults Living with HIV: Training Peer Research Associates in the Implementation of a Community-Based Research Project; PANACHE Ontario Study
EPHP11.05	Older People Living with HIV as Peer Research Associates:  Reflections on the Role and Experiences; PANACHE Ontario
CSP9.03	Characteristics of Individuals with Significant Depressive Symptoms among People Living with HIV in British Columbia

SCIENCES SOCIALES

SS1.01	The Perils of “Protection”: Sex workers’ experiences of law enforcement in Ontario
SS1.03	Criminalization of HIV Non-disclosure: another Mechanism of Social and Judicial Surveillance and Control of Black Women Living with HIV in Canada
SS1.04	Not in THIS backyard: HaliFIX OPS strategies for overcoming NIMBYism
SS1.05	Lessons Learned from Implementing Injectable Opioid Agonist Treatment in an Innovative Community Based Model
SS1.06	Condom use and HIV criminalisation in Canada
SS2.04	Capacity Bridging: Establishing Meaningful Collaboration between Peer Researchers and Academic Researchers in the Ontario Implementation of the HIV Stigma Index
SS2.05	The Butterfly Project: An Indigenous Community-Based Research, Knowledge Translation Project
SS2.06	Getting to Zero Manitoba a Collective Impact Approach
SS2.08	Engaging Communities as Allies in Harm Reduction
SS3.01	Index de la stigmatisation des personnes vivant avec le VIH (PVVIH) au Québec : Intersectionnalité et stigmatisation
SS3.03	Hiv and Improvement in Mental Health Symptoms Among Gay, Bisexual and Other Men Who Have Sex with Men (gbMSM) in Vancouver
SS3.05	Exploring Young, Black Gay, Bisexual and Other Men Who Have Sex with Men’s PrEP Knowledge in Toronto, Ontario
SS3.07	Reducing Risks While Increasing Sexual Pleasure: The Effects Of The Phénix Program For GbMSM
SS3.08	Sexual Practices among Two-Spirit, Gay, Bisexual, and Queer Men of Different HIV Statuses in Manitoba
SS4.01	Examining land-based and Indigenous approaches to HIV and STI prevention with Northern and Indigenous Young Women in the Northwest Territories
SS4.02	Mapping the Journey: Developing Culturally Appropriate, Geographically-responsive HIV Care for Northern Manitoba First Nations People
SS4.05	Creating a Métis-specific Model of Culturally-Relevant Shared Care for Métis Individuals living with or affected by HIV/STBBI
SSKP2.02	Evaluating Dried Blood Spot Testing from a Métis Community Perspective
SSP1.01	Using Text Mining to Evaluate Quality of Free-Text Health Goals in People with HIV: Proof-of-Concept
SSP1.02	An Affirmative Coping Skills Intervention to Improve Mental and Sexual Health of Sexual and Gender Minority Youth (Youth AFFIRM): Interim Results of an Implementation Study
SSP2.01	Long-overdue and still deficient: the Correctional Service Canada’s Prison Needle Exchange Program
SSP2.02	A time of vulnerability: People who use substances’ emotional lives and substance use when unable to access or stay in addiction treatment
SSP2.03	Perspectives of People Living with HIV Regarding the Feasibility and Desirability of Implementing Supervised Injection Services in a Speciality HIV Hospital
SSP2.04	Supervised Consumption Services Design: a Scoping Review of Stakeholder Opinions
SSP4.01	Building Community Capacity in Affirmative Cognitive Behavioural Therapy for Sexual and Gender Minority Youth: Effectiveness of AFFIRM Facilitator Training
SSP4.02	Community Engagement in HIV Research: Lessons Learned from Four Studies
SSP4.05	Beyond Mending Bridges: Decolonising Research Structures Through Co-creating Respectful and Equitable Indigenous-Settler PLHIV Partnerships
SSP4.06	Embodied and Evolving Indigenous HIV Leadership: An Example from GIPA Homefire
SSP4.07	Identifying the Value of Peer Support by Bringing Community Based Research To Our Work With Positive Women in Toronto
SSP4.08	Co-designing care improvements for women living with HIV: a deliberative dialogue workshop in Montréal, Québec.
SSP4.12	The Role of Peer Research Associates in Collecting Complete Data in Longitudinal Health Surveys
SSP5.01	What is the role of sub-cultural identification in the sexual lives of gay, bisexual, and other men who have sex with men?
SSP5.02	Psychosocial predictors of crystal methamphetamine use among gay, bisexual and other men who have sex with men (gbMSM): The importance of depression and cognitive escape
SSP5.04	Substance Use in Syndemic Conditions: Substance Use Stigma and the Mental Health of Sexual Minority Men
SSP5.05	Barriers and facilitators to PrEP use in Barbados among gbMSM
SSP5.06	Double Minority: Childhood Maltreatment and Psychological Distress among Immigrant Gay, Bisexual and Other Men who have Sex with Men in Toronto
SSP6.01	Re-thinking current policy: Challenging social structures surrounding mandatory HIV screening during the Canadian Immigration Medical Examination (IME)
SSP7.01	Positive Outlook Workshop: Supporting the Well-Being of Those Working With People Living With HIV
SSP7.05	The “Weaving Our Wisdoms” Study, a Positive Action Initiative to Support Indigenous People Living with HIV and AIDS: Findings from a Gathering on the Land
SSP7.06	“My heart’s full. My spirit’s flying”: Creating a CHIWOS-PAW Gathering for Indigenous Women Living with HIV in the Coast Salish Territories
SSP7.08	Using a Two-Eyed Seeing Approach to Realist Evaluation in a Community-Based Research Project
SSP7.09	Kotawe (start a fire): Igniting cultural responsiveness through community-determined intervention research
SSP8.01	Vulnerability and Resilience: the Lived Experience of Women Who Receive an HIV Diagnosis During the Resettlement Process
SSP8.02	Clients Drive the Supplementary Food Program for HIV+ Community
SSP8.03	Factors Associated with Willingness to Participate in End-of-Life Cure Research: Perspectives from People Living with HIV
SSP8.04	Diet Quality, Cardiovascular Disease Risk Factors and Diabetes Prevalence Among Canadians Living with HIV Engaged in a Study About Health Behaviors
SSP8.07	A Provincial Overview of Community-Based Organizational Supports for Older Adults Living with HIV in British Columbia
SSP8.08	Shortening the HIV Disability Questionnaire (HDQ) for use in Clinical Practice: A Rasch Analysis
SSP8.09	Accès aux soins dentaires pour les personnes vivant avec le VIH (PVVIH) : Aperçu de la situation au Québec en 2019
SSP8.10	Impact of Health Risks and Protective Factors on Dimensions of Stigma and Overall Health in People Living with HIV: Results from the Ontario HIV Stigma Index
SSP8.11	Desire for place attachment in healthcare among people living with HIV: Perspectives of potential clients of a forthcoming day health program in a specialty HIV hospital
SSP8.12	Community Connectedness and Correlates of ART Interruptions Among HIV-Positive gbMSM in Vancouver
SSP8.13	A Sip of C.A.R.E. for Marginalized East and Southeast Asian Communities in Toronto
SSP8.14	The Desire to Leave a Financial Legacy – Life Insurance and People Living with HIV in Canada
SSP9.01	Community pharmacist-facilitated HIV PrEP and hepatitis C treatment in Ontario
SSP9.02	Reducing Barriers Through Atlantic Canada’s First Overdose Prevention Site (OPS)
SSP9.03	Keeping Secrets or Disclosing Health Information?: Accounting for Women’s Concerns about HIV Disclosure in Maternity Care
SSP9.04	Meeting People Where They’re At; Helping Them to Get Where They Want To Go: A case study of harm reduction nursing care and cross-agency collaboration
SSP9.07	Prélib: evaluating a newly launched Canadian provider of innovative internet-based services for self-directed HIV and STI screening
SSP9.08	Implementing Physiotherapy in an HIV Community-Based Care Setting: a Qualitative Study of Perspectives from People Living with HIV and Health Care Providers
SSP10.02	Treatment Needs, Aspirations, and Polypharmacy: a Positive Perspective Among Persons Living with HIV in Canada
SSP11.01	HIV and Physical Activity – Actively Working Together to Make a Change
SSP11.02	The CanCURE Post-mortem HIV Tissue Biobank: Working Together Towards an HIV Cure
SSP11.03	Project PEER: Uncovering the Impact of GIPA/MEPA and the Wise Practices of Informal and Formal Supports
SSP11.04	Challenges to Accessing Drug Addiction Treatment: the Perspectives of People Who Use Substances Living in Atlantic Canada
SSP11.05	GetCheckedOnline Ontario?: Exploring Digital STI Testing in a Context of Political-Economic Complexity
SSP13.01	Loneliness, Social Support, and Sexual Health Behaviours Among Gay, Bisexual, and Other Men who Have Sex with Men (GBM)
SSP14.03	Sociopolitical Contexts of Health and HIV Vulnerability among Heterosexual African Caribbean and Black (ACB) Men in Ottawa
SSP14.04	Undoing the Unseen: Stigma and its reduction among African, Caribbean, and Black Women Living with HIV in Ontario
SSP14.05	The Dangers of Mass Media and Pop Culture in Relation to HIV Vulnerability: a Case Study of Young African, Caribbean and Black Canadian (ACB) Men in Windsor, Ontario
SSP14.06	HIV Vulnerability and Resilience among Heterosexual African, Caribbean and Black (ACB) Men in Windsor, Ontario: a Perspective of Service Providers
SSP14.07	African, Caribbean and Black (ACB) Women Taking Control over HIV/AIDS and Sexual Health:  A sustainable model for culturally responsive and evidenced based HIV prevention
SSP15.01	Messaging Transmission: A Qualitative Analysis of Factors in the Uptake of U=U in Canadian Public Health Messaging
SSP15.02	“1 + 1 = 0 / HIV + Effective treatment = 0 sexual transmission”: The process of creating a simple message about U=U without saying U=U in Quebec, Canada
SSP16.01	Addressing An Unmet Need: Young Women ≤30 Years Living with HIV (Often Overlooked and Highly Vulnerable)

POPULATIONS CLÉS

 

KP1.06	The A/C Study: a Cross-Sectional Study of HIV Epidemiology Among African, Caribbean and Black People in Ontario
KP2.05	Exploring the Efficacy of FOXY and SMASH Arts-based HIV Prevention strategies with Northern and Indigenous Youth: Implications for tailored HIV Prevention
KP2.06	HIV Prevention and Care among Indigenous Two-Spirit, Gay, Bisexual, and Queer Men in Manitoba
KP3.03	Substance Use Patterns Among Gay, Bisexual and Other Men Who Have Sex with Men in Toronto, Vancouver and Montreal: Results from the Engage Study
KP3.04	The Adherence and Community Engagement (ACE) Team- An Inner City Outreach Team Improving Adherence and Linkage to Care for High Barrier Individuals Who Live with HIV
KP4.03	« Canada’s Got Talent » — Trans Latinas Ontario (TLO) & Economic Integration Through Employment. A program for HIV+/- Individuals, HIV Prevention Program, CSSP
KP4.05	HIV Testing and PrEP Use among Manitoba’s Two-Spirit, Gay, Bisexual, and Queer Men